Photo Therapeutics Establishes Direct Operation in USA 3rd November 2005
Photo Therapeutics Limited, a global developer, manufacturer and seller of FDA
approved, LED-based low level light therapy devices, today announced the opening of
Photo Therapeutics, Inc in Lake Forest, California, in order to manage directly the growth
in demand in the United States for its OmniluxTM range of LED technology. The office will
manage the Marketing and Selling activities within North America, as well as the
extensive US-based clinical trial programme. Also housed within this Orange County
facility will be highly trained service and support engineers.
"The OmniluxTM customer base has been growing in the United States since June 2003
when we received our first FDA approval for the treatment of acne with OmniluxTM
Blue", said Sue D'Arcy, President and Chief Executive Officer of Photo Therapeutics, Inc.
"To date, we have worked in the USA through partner companies but have now judged
that the time is right for a direct presence in this, the largest market in the world for
medical and aesthetic devices."
"The OmniluxTM platform enables our customers to enter the world of therapeutic light
devices with a clinically proven, safe and cost effective technology that will never become
obsolete" added Dr Colin Whitehurst, Director of Research and Development for Photo
Therapeutics. "Our global clinical trial programme enables us to offer treatment protocols
that have been optimised for a growing number of applications, and effective on all skin
types. OmniluxTM is delivering highly effective, pain-free outcomes for patients seeking
treatment for acne, skin rejuvenation, psoriasis, woundhealing, non-melanoma skin cancer
and many more conditions, with a pipeline of therapies currently undergoing clinical
trials in the USA, UK, Australia, France, Japan and Korea."
"The acceptance of OmniluxTM by both practitioners and patients is growing rapidly,"
continued D'Arcy "and by concentrating on the development of our business in the US
market we will further influence those practitioners in the rest of the world who seek to
emulate the best practice within the USA.